Biotest

Biotest

World Rank (Jan-05-2024)
6,541
Market Cap (Jan-05-2024)
1.590 Billion USD
World Rank (Jul-30-2023)
6,536
Market Cap (Jul-30-2023)
1.623 Billion USD
World Rank (Jan-07-2022)
6,569
Market Cap (Jan-07-2022)
1.871 Billion USD
World Rank (Jan-01-2021)
6,717
Market Cap (Jan-01-2021)
1.371 Billion USD
Company Rank in Country in 2023
Rank in Germany in July-2023 is 132
Headquarters Country
Germany
World Region
Europe
World Subregion
Western Europe
Annual Revenue in USD
569 Million USD
Annual Operating Income in USD
-9 Million USD
Annual Net Income in USD
-35 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
1,326 Million USD
Total Liabilities in USD
916 Million USD
Total Equity in USD
409 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Biotechnology
Company Website
BIOTEST
Yahoo
Yahoo @ Germany
Company Profile
Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine company develops, manufactures and markets plasma proteins and biotherapeutic drugs. It is having more than 1,900 employees. The company annual revenue is 484.2 million EUR and total assets are 1,131.3 million EUR as on 2020. The headquarters is in Germany.
Founded Year
1946
ISIN Code
DE0005227201
Stock Exchange
Deutsche Borse
Company SubCategory
Top Healthcare Companies in Europe

Share